US3085935A - Method for the elimination of nematode infestations - Google Patents

Method for the elimination of nematode infestations Download PDF

Info

Publication number
US3085935A
US3085935A US104798A US10479861A US3085935A US 3085935 A US3085935 A US 3085935A US 104798 A US104798 A US 104798A US 10479861 A US10479861 A US 10479861A US 3085935 A US3085935 A US 3085935A
Authority
US
United States
Prior art keywords
infestations
elimination
host
worms
intestinal tract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US104798A
Inventor
Arthur P Phillips
Robert B Burrows
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Burroughs Wellcome Co USA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NL277327D priority Critical patent/NL277327A/xx
Application filed by Burroughs Wellcome Co USA filed Critical Burroughs Wellcome Co USA
Priority to US104798A priority patent/US3085935A/en
Priority to US115996A priority patent/US3075975A/en
Priority to GB22626/61A priority patent/GB1009301A/en
Priority to DE19621470413 priority patent/DE1470413A1/en
Priority to CH480662A priority patent/CH413836A/en
Priority to ES276612A priority patent/ES276612A1/en
Priority to DK179562AA priority patent/DK104234C/en
Priority to AT945364A priority patent/AT248792B/en
Priority to AT328762A priority patent/AT239218B/en
Priority to LU41596D priority patent/LU41596A1/xx
Priority to BR138334/62A priority patent/BR6238334D0/en
Priority to FR895386A priority patent/FR1841M/en
Priority to FR895385A priority patent/FR1320520A/en
Application granted granted Critical
Publication of US3085935A publication Critical patent/US3085935A/en
Priority to OA52810A priority patent/OA02352A/en
Priority to MY196793A priority patent/MY6700093A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Definitions

  • the present invention relates to the discovery that the following novel group of di-stilbazoles, expressed in Formula I, have marked activity against nematode infestations of the intestinal tract
  • R is selected from the class consisting of methyl, ethyl, n-propyl, n-butyl and benzyl radicals
  • R is selected from the class consisting of the methyl and ethyl radicals
  • NR may also be pyrrolidino or piperidino
  • X-* is the anion of a non-toxic pharmaceutically acceptable acid.
  • the parasites of particular concern are pin-worms (Enterobius vermicularis, Syphacia obvelata and Aspicul'uris tetraptera of mice) and hook-worms (Ancylostoma duodenale and Necator americanus and Ancylostoma caninum of dogs).
  • the pin-worms of mice are primarily of interest as test-organisms, Syphacia especially having been found to be a reliable indicator of the elfectiveness of drugs against human pin-worm.
  • the hook-worms of dogs are both test-organisms and parasites of some importance in their own right since severe infestations by canine hook-worm are common among dogs in the South of the United States, and light infestations are fairly frequent in the North.
  • R cannot be a branched group and its size is pretty well limited at four carbons.
  • iodide ion is sufliciently nontoxic. Bromide or chloride or methyl sulfate and ptoluene sulfonate are other convenient values for X cates the critical character of the structure-activity relationships. All of these results were obtained with single doses administered orally. It will be observed (cf. cpds. I-V) that substitution by a [dialkylamino group in the benzenoid rings is essential for high activity and that this substitution must be in the para position (compare III and V). Auxiliary substitution is undesirable (compare IV and V).
  • NR has an acceptable value, R may vary considerably. It will be seen from the table that all variations of R Within the definition give active compounds. Of these, however, the methiodides and ethiodides are very much the most accessible.
  • 2,-6-bz's (p-pyrrolidinostyryl) pyridine ethiodide compound XII of the table.
  • a mixture containing 2.6 g. of 2,6-lutidine ethiodide, 100 cc. of methanol, 4.2 g. of p-pyrrolidinobenzaldehyde and 1 cc. of piperidine was refluxed on a steam bath. Insoluble solid precipitated and heavy bumping started in less than one hour. After 2 hours this product was collected (2 g.) and the filtrates were refluxed for 20 hours longer. A second crop of 2.5 g. was obtained and on standing another day or so the filtrates gave a third crop of one g. The total yield was 5.5 g.
  • a method of eradicating infestations of parasitic nematodes inhabiting the intestinal tract which comprises administering orally to the host of the infested locus a compound represented by the formula nematodes inhabiting the intestinal tract which comprises administering orally to the host of the infested locus 2,6- bis (p-dimcthylaminostyryl) pyridine methiodide.
  • a method of eradicating infestations of parasitic nematodes inhabiting the intestinal tract which comprises administering orally to the host of the infested locus 2,6-bis (p-dimethylaminostyryl)pyridine benzyl iodide.
  • a method of eradicating infestations of parasitic nematodes inhabiting the intestinal tract which comprises administering orally to the host of the infested locus 2,6-bis (p-pyrrolidinostyryl) pyridine ethiodide.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

United States Patent York No Drawing. Filed Apr. 24, 1961, Ser. No. 104,798 6 (Ilaims. (Ql. 167-53) The present invention relates to the discovery that the following novel group of di-stilbazoles, expressed in Formula I, have marked activity against nematode infestations of the intestinal tract In the above formula R is selected from the class consisting of methyl, ethyl, n-propyl, n-butyl and benzyl radicals, R is selected from the class consisting of the methyl and ethyl radicals, and NR may also be pyrrolidino or piperidino and X-* is the anion of a non-toxic pharmaceutically acceptable acid.
The parasites of particular concern are pin-worms (Enterobius vermicularis, Syphacia obvelata and Aspicul'uris tetraptera of mice) and hook-worms (Ancylostoma duodenale and Necator americanus and Ancylostoma caninum of dogs). The pin-worms of mice are primarily of interest as test-organisms, Syphacia especially having been found to be a reliable indicator of the elfectiveness of drugs against human pin-worm. The hook-worms of dogs are both test-organisms and parasites of some importance in their own right since severe infestations by canine hook-worm are common among dogs in the South of the United States, and light infestations are fairly frequent in the North.
Some of the compounds of Formula I have been described previously but none have ever been examined as anthelmintics. The doses required vary somewhat with the parasite and with the host, and rather less with the individual compounds. Against mouse pin-worms oral doses of 5-20 mg./kg. eliminate all or virtually all the worms in one treatment. With dogs hook-worms are well eliminated by compound V (Table I) in a single dose of 25 trig/kg. The whip-worm, Trz'curis vulpis, requires the same sized dose but repeated twice a day for three days. The common round-worm of dogs (Toxocara canz's) is also vulnerable to this compound.
These compounds are conveniently prepared by condensation or" two equivalents of an aldehyde:
with a quarternary salt of 2,6-lutidine The condensation is conveniently run in a lower alcohol with a secondary amine, such as piperidine, as catalyst. When X- in the above formula is iodide ion (correspond- 3,085,935, Patented Apr. 16, 1963 ing to an .alkiodide of lutidine) the condensation product, I, is relatively insoluble and precipitates in the course of the reaction. The yields of I, so obtained, are nearly quantitative.
Of the p-dialkylaminobenzaldehydes required for this synthesis, padimethylamino and p-diethylaminobenzaldehydes are known. The preparation of p-pyrrolidino and p-piperidinobenzaldehydes is described in a companion application. The nature of R, beyond being a lower alkyl.
group, is pretty well determined by the chemistry of the situation. The normal diminution in the reactivity of alkyl halides with the increasing size of the alkyl group is here accentuated by the hindrance of the 2,6-lutidine.
As a result R cannot be a branched group and its size is pretty well limited at four carbons. The more reactive benzyl is, however, usable.
In the doses employed iodide ion is sufliciently nontoxic. Bromide or chloride or methyl sulfate and ptoluene sulfonate are other convenient values for X cates the critical character of the structure-activity relationships. All of these results were obtained with single doses administered orally. It will be observed (cf. cpds. I-V) that substitution by a [dialkylamino group in the benzenoid rings is essential for high activity and that this substitution must be in the para position (compare III and V). Auxiliary substitution is undesirable (compare IV and V). Taking p-dialkylamino substitution as essential it will be seen that high activity ceases above diethylamino (VIII-X) but that pyrollidino and piperidino are satisfactory values for NR Morpholino and N'-alkyl piperazino substitutions give relatively inactive compounds (XVI-XVII).
Provided NR has an acceptable value, R may vary considerably. It will be seen from the table that all variations of R Within the definition give active compounds. Of these, however, the methiodides and ethiodides are very much the most accessible.
PREPARATION OF THE DI-STILBAZOLES All of the di-stilbazoles were prepared by essentially thesame method. Compounds V and VI of Table I were reported by Crippa and Verdi (Ann. chim. applioata, 26, 418 (1936) (Chem. Abs. 31, 2214" (1937).
2,-6-bz's (p-pyrrolidinostyryl) pyridine ethiodide (compound XII of the table).A mixture containing 2.6 g. of 2,6-lutidine ethiodide, 100 cc. of methanol, 4.2 g. of p-pyrrolidinobenzaldehyde and 1 cc. of piperidine was refluxed on a steam bath. Insoluble solid precipitated and heavy bumping started in less than one hour. After 2 hours this product was collected (2 g.) and the filtrates were refluxed for 20 hours longer. A second crop of 2.5 g. was obtained and on standing another day or so the filtrates gave a third crop of one g. The total yield was 5.5 g. (-85%) in three crops, M.P. 282-283 C. The product was nearly insoluble in hot methanol and was purified by washing several times With ether and then digesting one or two times with 10-20 times its weight of hot methanol. Because it is difficult to recrystallize it is desirable that nearly all insoluble impurities (dust, boiling stones, etc.) be removed from the easily purified reactants before the final condensation step and be kept out as much as possible thereafter.
Table I Substitution in benzene rings Percent worms removed Dose. nag/Kg.
4-CH3O 2-N(CH3) z--CH3 VII-..
VIII
XVII.
4-N(CH CH2CH:)2
4-N(CH:C5H5)2 C H5CH2 11-C4Hn M \I HM HHN} r-u- N: i-nm HM t- Nn- M HMP-M' l-u- 00 010010 0010 momo 01cc ooooovoooouvmcuocovcncuv oncom amazes 10:08 soccer: in! umzocow woocomscnzozo sm M coo ours wooco oo cnqacr ONO: vm wficcoworocawqoww-q owitmmuomw These substances can be presented in capsules or as compressed tablets or can be administered in a chewing wafer.
What we claim is: 1. A method of eradicating infestations of parasitic nematodes inhabiting the intestinal tract which comprises administering orally to the host of the infested locus a compound represented by the formula nematodes inhabiting the intestinal tract which comprises administering orally to the host of the infested locus 2,6- bis (p-dimcthylaminostyryl) pyridine methiodide.
3. A method of eradicating infestations of parasitic nematodes inhabiting the intestinal tract which comprises administering orally to the host of the infested locus 2,6 bis (p-diethylaminostyryl) methiodide.
4. A method of eradicating infestations of parasitic nematodes inhabiting the intestinal tract which comprises administering orally to the host of the infested locus 2,6-bis (p-dimethylaminostyryl) pyridine ethiodide.
5. A method of eradicating infestations of parasitic nematodes inhabiting the intestinal tract which comprises administering orally to the host of the infested locus 2,6-bis (p-dimethylaminostyryl)pyridine benzyl iodide.
6. A method of eradicating infestations of parasitic nematodes inhabiting the intestinal tract which comprises administering orally to the host of the infested locus 2,6-bis (p-pyrrolidinostyryl) pyridine ethiodide.
No references cited.

Claims (1)

1. A METHOD OF ERADICATING INFESTATIONS OF PARASITIC NEMATODES INHABITING THE INTESTINAL TRACT WHICH COMPRISES ADMINISTERING ORALLY TO THE HOST OF THE INFESTED LOCUS A COMPOUND REPRESENTED BY FORMULA
US104798A 1961-04-24 1961-04-24 Method for the elimination of nematode infestations Expired - Lifetime US3085935A (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
NL277327D NL277327A (en) 1961-04-24
US104798A US3085935A (en) 1961-04-24 1961-04-24 Method for the elimination of nematode infestations
US115996A US3075975A (en) 1961-04-24 1961-06-07 Anthelmintic distilbazoles and method
GB22626/61A GB1009301A (en) 1961-04-24 1961-12-22 Styryl-pyridinium compounds, the preparation thereof, and pharmaceutical compositions thereof
DE19621470413 DE1470413A1 (en) 1961-04-24 1962-04-16 Quaternary ammonium compounds, their manufacture and pharmaceutical preparations
ES276612A ES276612A1 (en) 1961-04-24 1962-04-18 A method for the preparation of diestilizabol compounds (Machine-translation by Google Translate, not legally binding)
DK179562AA DK104234C (en) 1961-04-24 1962-04-18 Process for the preparation of distilbazole compounds.
CH480662A CH413836A (en) 1961-04-24 1962-04-18 Process for the preparation of distilbazoles
AT945364A AT248792B (en) 1961-04-24 1962-04-20 Method for the treatment of nematode worm infections in animals
AT328762A AT239218B (en) 1961-04-24 1962-04-20 Process for the preparation of new quaternary ammonium compounds of distilbazole
LU41596D LU41596A1 (en) 1961-04-24 1962-04-21
BR138334/62A BR6238334D0 (en) 1961-04-24 1962-04-23 A PROCESS FOR THE PREPARATION OF CATION DISTILBAZOL COMPOUNDS
FR895386A FR1841M (en) 1961-04-24 1962-04-24 Medicinal product based on a quaternary salt derived from distilbazole.
FR895385A FR1320520A (en) 1961-04-24 1962-04-24 Quaternary salts of distilbazole derivatives
OA52810A OA02352A (en) 1961-04-24 1967-03-11 Quaternary salts of distibazole derivatives.
MY196793A MY6700093A (en) 1961-04-24 1967-12-31 Styryl-pyridium compounds, the preparation thereof, and pharmaceutical compositions thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US104798A US3085935A (en) 1961-04-24 1961-04-24 Method for the elimination of nematode infestations

Publications (1)

Publication Number Publication Date
US3085935A true US3085935A (en) 1963-04-16

Family

ID=22302443

Family Applications (1)

Application Number Title Priority Date Filing Date
US104798A Expired - Lifetime US3085935A (en) 1961-04-24 1961-04-24 Method for the elimination of nematode infestations

Country Status (2)

Country Link
US (1) US3085935A (en)
AT (2) AT239218B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873312A (en) * 1973-05-04 1975-03-25 Eastman Kodak Co Photoconductive composition and elements containing a styryl amino group containing photoconductor
US3883658A (en) * 1968-09-19 1975-05-13 Burroughs Wellcome Co Method of treating nematode infestations
US4558133A (en) * 1979-08-08 1985-12-10 Bayer Aktiengesellschaft p-(Pyridinium-vinyl)-N,N-(disubstituted-aniline salts for dyeing paper and their preparation
US5360911A (en) * 1993-06-17 1994-11-01 General Electric Company Process for the preparation of stilbazolium salts
US20030138374A1 (en) * 2000-03-22 2003-07-24 Yukitsuda Kudo Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same
WO2004078136A2 (en) * 2003-03-03 2004-09-16 Mycosol, Inc. Pyridinium salts, compounds and methods of use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883658A (en) * 1968-09-19 1975-05-13 Burroughs Wellcome Co Method of treating nematode infestations
US3873312A (en) * 1973-05-04 1975-03-25 Eastman Kodak Co Photoconductive composition and elements containing a styryl amino group containing photoconductor
US4558133A (en) * 1979-08-08 1985-12-10 Bayer Aktiengesellschaft p-(Pyridinium-vinyl)-N,N-(disubstituted-aniline salts for dyeing paper and their preparation
US5360911A (en) * 1993-06-17 1994-11-01 General Electric Company Process for the preparation of stilbazolium salts
WO1996008474A1 (en) * 1993-06-17 1996-03-21 Molecular Optoelectronics Corporation Process for the preparation of stilbazolium salts
US20030138374A1 (en) * 2000-03-22 2003-07-24 Yukitsuda Kudo Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same
WO2004078136A2 (en) * 2003-03-03 2004-09-16 Mycosol, Inc. Pyridinium salts, compounds and methods of use
US20040224984A1 (en) * 2003-03-03 2004-11-11 Selph Jeffrey L. Methods of treating inflammations and infections with pyridinium salts
WO2004078136A3 (en) * 2003-03-03 2004-12-16 Mycosol Inc Pyridinium salts, compounds and methods of use
US7220761B2 (en) 2003-03-03 2007-05-22 Mycosol, Inc. Compounds and methods for controlling fungi, bacteria and insects
JP2007525441A (en) * 2003-03-03 2007-09-06 マイコソル,インコーポレイテッド Pyridinium salts, compounds and methods of use
US7547444B1 (en) 2003-03-03 2009-06-16 Mycosol, Inc. Methods for controlling fungi and bacteria
US7820696B2 (en) 2003-03-03 2010-10-26 Mycosol, Inc. Compounds and methods for controlling fungi, bacteria and insects
JP4742028B2 (en) * 2003-03-03 2011-08-10 マイコソル,インコーポレイテッド Pyridinium salts, compounds and methods of use
US8124626B2 (en) 2003-03-03 2012-02-28 Mycosol, Inc. Methods of treating inflammations and infections with pyridinium salts

Also Published As

Publication number Publication date
AT248792B (en) 1966-08-10
AT239218B (en) 1965-03-25

Similar Documents

Publication Publication Date Title
DE2635276A1 (en) TETRAHYDROISOCHINOLINE DERIVATIVES, THE PROCESS FOR THEIR PRODUCTION AND MEDICINAL PREPARATIONS CONTAINING THESE COMPOUNDS
DE1545995B2 (en) DL-IMIDAZO SQUARE BRACKET ON 2.1 SQUARE BRACKET FOR THIAZOLE CONNECTIONS AND THE PROCESS FOR THEIR PRODUCTION
US3085935A (en) Method for the elimination of nematode infestations
US3061517A (en) Antihistamine composition and method
DE1545575B1 (en) N, N'-bis [3- (3 ', 4', 5'-trimethoxybenzoyloxy) propyl] homopiperazine
DE68907095T2 (en) Compounds for preventing biosynthesis of arachidonic acid metabolites derived from lipoxygenase.
DE2416016A1 (en) NEW SINGLE-SQUARE CLIP ON BETA- (AMINOCARBONYLPHENOXY) -AETHYLAMINO SQUARE CLIP FOR -3- (THIAZOL-2-OXY) -2-PROPANOLS AND ITS DERIVATIVES
EP0152868B1 (en) Isoxazole derivatives, process for their preparation, and pharmaceuticals containing these compounds
US3366629A (en) Alkaloids of mitragyna ciliata
DE1212090B (en) Process for the preparation of 10- (piperazinopropyl) -3-trifluoromethyl-phenothiazine compounds and their salts
US2807617A (en) Acylpiperazines and methods of preparing the same
EP0075140A1 (en) Tricyclic thiazolyl oxamic acids and derivatives, process for their production, and therapeutic agents containing them
US2890982A (en) Method of combatting helminthiasis using nitro-furyl-acrylate derivatives
Smith CCLXX.—l-Methylephedrine, an alkaloid from Ephedra species
US3152042A (en) Styrylquinolinium compositions used as anthelmintics
DE1695855B2 (en) 4- (5-Isobutyl-2-pyrimidinyl) sulfonamidophenylacetic acid (2-methoxy-5-chloroanilide) and its salts with physiologically compatible bases
DE2624918A1 (en) MEDICINAL PRODUCTS WITH ANTIARRHYTHMIC EFFECT
US3829581A (en) Aliphatic polycyclic amidoximes as influenza antiviral agents
US3256149A (en) Compositions comprising an alkaloid of mitragyna speciosa and methods of using same
US3629418A (en) Process for producing an anti-depressant effect with piperazine quinolines
DE2819215C2 (en)
US3052679A (en) Heterocyclicaminoalkyl ethers of
DE2935062A1 (en) SUBSTITUTED AMINOALKYLGUANIDINE, THEIR PRODUCTION AND MEDICINAL PRODUCTS
DE2725245A1 (en) METHYLAMINE DERIVATIVES, THE PROCESS FOR THEIR PRODUCTION AND THE PHARMACEUTICAL OR VETERINARY MEDICAL COMPOSITIONS THEREOF
US3452030A (en) 4-(n-isobutyrylanilino)-1-benzylpiperidine